Oxford Sciences Innovation
Investor profile
Deals
12
distinct rounds
Companies
11
backed
Active span
2017–2021
5 yrs
Total round €
€224M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- GT Healthcare Capital & Partners2
- Tanarra2
- Woodford Investment Management2
- Adage Capital Management1
- Andre Crawford-Brunt1
- Blue Venture Fund1
- Borealis Ventures1
- CureDuchenne Ventures1
- Deerfield1
- Dieter Spälti.1
- Force Over Mass Capital1
- Fushia1
- Goldman Sachs Principal Strategic Investments1
- Gray’s Creek Capital Partners1
- GV1
- Invesco Perpetual1
- IQ Capital1
- Kapil Dev Joory1
- Lansdowne Partners1
- Laurion Capital Management1
- Neptune1
- Optum Ventures1
- Oxford Technology and Innovations EIS Fund (OTIF)1
- Oxford Technology and Innovations Fund1
- Parkwalk Advisors1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Pepgen | UK | 1 | €96M |
| Ultromics | UK | 2 | €39M |
| Genomics | UK | 1 | €28M |
| DiffBlue | UK | 1 | €20M |
| Base Genomics | UK | 1 | €9.8M |
| Animal Dynamics | UK | 1 | €6.8M |
| Bodle | UK | 1 | €6.7M |
| Orbit Discovery | UK | 1 | €6.4M |
| Metaboards | UK | 1 | €4.3M |
| Oxford VR | UK | 1 | €3.6M |
| BioBeats | Italy | 1 | €2.6M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Pepgen | Other | €96M | 2021-08 |
| Genomics | Series B | €28M | 2018-09 |
| Ultromics | Series B | €28M | 2021-08 |
| DiffBlue | Series A | €20M | 2017-06 |
| Ultromics | Series A | €11M | 2018-01 |
| Base Genomics | Seed | €9.8M | 2020-03 |
| Animal Dynamics | Series A | €6.8M | 2018-11 |
| Bodle | Other | €6.7M | 2017-12 |
| Orbit Discovery | Other | €6.4M | 2021-07 |
| Metaboards | Other | €4.3M | 2018-01 |